[1] PAUL E GOSS. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.[J]. Clinical Cancer Research, 2004, 10 17: 5717-5723. DOI:
10.1158/1078-0432.ccr-04-0438[2] LANDRY K KAMDEM Z D David A Flockhart. In vitro cytochrome P450-mediated metabolism of exemestane.[J]. Drug Metabolism and Disposition, 2011, 39 1: 98-105. DOI:
10.1124/dmd.110.032276[3] FRANCO BUZZETTI . Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione)[J]. Steroids, 1993, 58 11: Pages 527-532. DOI:
10.1016/0039-128x(93)90029-m[4] ERIC A ARIAZI. Exemestane’s 17-hydroxylated metabolite exerts biological effects as an androgen.[J]. Molecular Cancer Therapeutics, 2007: 2817-2827. DOI:
10.1158/1535-7163.mct-07-0312[5] CARLA L. VARELA . Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line[J]. European Journal of Medicinal Chemistry, 2014, 87: Pages 336-345. DOI:
10.1016/j.ejmech.2014.09.074